13-year-old Terry Emmanuel Louise was at risk of heart failure as he was not able to get a heart transplant amid the COVID-19 pandemic. Our team at Gleneagles Global Health City, Chennai, successfully performed a left ventricular assist device (LVAD) implantation surgery, allowing Terry’s heart to keep functioning while he awaits a heart transplant.
Terry suffers from cardiomyopathy, a disease of the heart muscle which makes it harder for the heart to pump blood to the rest of the body, potentially leading to heart failure. He was repeatedly admitted to the hospital with symptoms of fluid overload which required inotropic infusion and intravenous diuretics.
As a heart transplant was not immediately possible amid the COVID-19 pandemic, the LVAD implant was the only option to prevent his condition from deteriorating further.
For this procedure, a ventricular assist device (VAD) was implanted in Terry’s left ventricle. It is a mechanical pump that supports heart function and blood flow for people with weakened hearts. It stimulates a healthy heart, taking blood from a lower chamber of the heart and pumping it to the body and vital organs.
With this implantation surgery, Terry’s heart is now able to continue functioning while he waits for a donor heart.
Related Stories
Fortis Healthcare Expands Footprint with New 200-Bed Hospital in Greater Noida
See how Fortis strengthens its Delhi-NCR network and enhances access to quality care.
Fortis Manesar Breaks New Ground in Cardiac Care
Discover how a life-changing, minimally invasive procedure gave a 16-year-old patient a second chance
IHH Healthcare Debuts FutureHealth.Now Conference
See how we united visionary minds across healthcare, government and business to spark bold ideas and forge new partnerships that will push the boundaries of care at our inaugural global leadership conference.
Unveiling Our New IHH Healthcare Identity
Prince Court Medical Centre Performs Malaysia’s First Kelly Procedure
